Spots Global Cancer Trial Database for adult malignant mesenchymoma
Every month we try and update this database with for adult malignant mesenchymoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | NCT00006357 | Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | imatinib mesyla... | 15 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | NCT00002995 | Sarcoma | dactinomycin filgrastim sargramostim cyclophosphamid... vincristine sul... radiation thera... | - 49 Years | Children's Oncology Group | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | NCT00003939 | Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine... | trabectedin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | NCT00002641 | Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera... | 16 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma | NCT00423618 | Sarcoma | radiotherapy | 16 Years - 120 Years | Sheffield Teaching Hospitals NHS Foundation Trust | |
| Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma | NCT00740597 | Sarcoma | gene expression... polymerase chai... western blottin... neoadjuvant the... therapeutic con... intensity-modul... | 18 Years - | City of Hope Medical Center | |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | NCT00410462 | Ovarian Cancer Sarcoma Small Intestine... | brostallicin doxorubicin hyd... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | NCT00030784 | Sarcoma | ifosfamide pegylated lipos... | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | NCT01189253 | Sarcoma | doxorubicin hyd... trabectedin laboratory biom... quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | NCT00077285 | Sarcoma | filgrastim carboplatin cyclophosphamid... dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... | - 50 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | NCT00003958 | Adult Malignant... Adult Rhabdomyo... Alveolar Childh... Childhood Malig... Embryonal Child... Embryonal-botry... Nonmetastatic C... Previously Untr... Stage I Adult S... Stage II Adult ... Stage III Adult... | dactinomycin vincristine sul... cyclophosphamid... therapeutic con... radiation thera... topotecan hydro... filgrastim sargramostim laboratory biom... | - 49 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group | |
| High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | NCT00354744 | Sarcoma | dactinomycin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide irinotecan hydr... vincristine sul... conventional su... radiation thera... filgrastim | - 49 Years | Children's Oncology Group | |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX | NCT00900211 | Sarcoma | microarray anal... molecular diagn... biologic sample... | 16 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
